• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Averhealth logo

Averhealth

Substance use monitoring and treatment solutions.

  • Court Solutions
    • Why Averhealth
    • Our Laboratory
    • Technology
  • Blog
  • Knowledge Hub
    • Press Releases
    • Testimonials
    • Newsletters
    • Annual Reports
    • Education
      • White Papers
    • Podcast
    • Webinars
  • Averhealth Academy
  • About
    • About Averhealth
    • Leadership
    • Careers
    • Job Openings
    • Certifications & Licenses
    • Our Partners
    • Conferences
    • Contact
    • Locations
    • Financial Affordability in Recovery (FAIR) Application
  • Log In
    • Provider
    • Patient
Dominique Hummel

Dominique Hummel

About Dominique Hummel

Dominique leads a nationwide team of managers and clinicians who operate Averhealth's laboratory and patient service centers across the United States. With more than 20 years of laboratory and substance-use experience, Dominique started her career in laboratory and substance-abuse testing and has served in senior management roles in operations, account management, and customer service. Dominique earned a bachelor's degree in business administration from Boston University with a concentration in operations management.

Turnaround Time Matters with So Much at Stake

10.02.23

No one likes to wait for anything. That’s certainly the case for results of lab-based drug testing. In addition to being accurate, lab-based testing also must include quick turnaround times – the period from specimen collection and shipment to the lab to results reporting.

Read More

Single Source: A Better Choice for Drug Testing

02.16.23

From collections to testing, we’re your total solution.

Read More

TIRED OF DOING COLLECTIONS? DITCH THE ICK FACTOR

02.03.23

Probation professionals know the drill. 

Despite staggering caseloads, many take precious time to, um, observe clients peeing into a cup.

Read More

Fentanyl – The Undercover Killer

11.15.22

“Rainbow fentanyl” is the nickname the United States Drug Enforcement Administration (DEA) has assigned to the brightly colored fentanyl that has recently been making its rounds across the country in the form of pills, powders, and blocks resembling sidewalk chalk. Despite its unassuming vibrant coloration, rainbow fentanyl is just as dangerous as any other, more conventionally colored fentanyl. 

Read More

A Covert Killer: The Deadly Trend of Fentanyl Lacing

08.22.22

According to the CDC, fentanyl overdose is now the leading cause of death among US adults between the ages of 18 and 45. While intentional fentanyl use accounts for many of these tragic fatalities, a growing percentage of individuals are overdosing due to unknowingly consuming fentanyl-laced substances. 

Read More

Building a Positive Work Environment with The R.A.P. Philosophy

04.25.22

The Averhealth management team recently met in person for education and training for the first time in two years. We were honored to have Dr. Jermaine Davis as our keynote speaker on the topic “Thriving as a Team.”

Read More
  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

BLOG SEARCH

Join Our Newsletter

Be the first to find out when we have exclusive news, articles or upcoming events to share.

Footer

  • Facebook
  • LinkedIn
 
866. 680. 3106
info@Averhealth.com

Newsletter Signup

Averhealth, Avertest, Aversys, and the associated logos and all associated marks are registered trademarks or service marks of Avertest, LLC.
© 2026 Avertest, LLC. All rights reserved.
The information provided on this website, including articles, laboratory guides, and compliance resources, is for educational and informational purposes only. It does not constitute professional medical advice, diagnosis, or treatment, nor does it establish a patient-provider relationship.

  • Lab Certifications
  • Non-Discrimination Notice
  • Compliance
  • Privacy Policy
  • texas Department of information resources
  • SAM registration